Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Conditions

Chalazion 2

Interventions

Conservative Treatment 3tyramine-deoxysorbitol 2Probiotics 2Curettage 2Triamcinolone Acetonide 1Triamcinolone 1Tetracycline 1Sevoflurane 1Loteprednol Etabonate 1Fluorouracil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Chalazion × tyramine-deoxysorbitol × Clear all
NCT03248440 2021-08-05

SUNRISE

Senju USA, Inc.

Phase 3 Completed
263 enrolled 7 charts

Chalazion

NCT02338648 2017-08-11

Safety and Efficacy Study of SUN 131 TDS as Compared to Placebo TDS in Adult Patients With a Chalazion

Senju USA, Inc.

Phase 2 Completed
60 enrolled

Chalazion

Data powered by HemOnc (CC BY 4.0) Colophon âš¡